Literature DB >> 15778980

Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women.

Brian Brestovac1, Gerry B Harnett, David W Smith, Geoffrey R Shellam, Felicity A Frost.   

Abstract

Human papillomavirus (HPV) is known to be the cause of almost all cervical cancers. The genotypes have been classified into high and low risk types according to their oncogenic potential. However, data for many of the genotypes are limited and some (HPV-26, 53, and 66) have no agreed status. A study was undertaken to determine the HPV genotype distribution in women of Western Australia and the association with cervical neoplasia. Liquid based cervical samples from a cohort of 282 Western Australian women were tested for HPV DNA by PCR followed by DNA sequencing to determine HPV genotypes. HPV-53 and HPV-16 were the most common genotypes found in this population. In addition 86 archived liquid based cervical samples from women with cervical intraepithelial neoplasia grades 1-3 (CIN 1-3) were tested for HPV DNA. Also 32 archived paraffin biopsy samples from women with squamous cell carcinoma were also tested. HPV-16 was the most common genotype found in these samples. Of the cohort of Western Australian women tested, 27% were found to contain HPV and approximately half of these contained known high-risk HPV genotypes, but only 30% of these were types 16 or 18. The data from this study indicate that HPV-53 is not oncogenic based on an R value and odds ratio (OR) of zero. The data also suggest that HPV-73 may be oncogenic, while HPV-66 is unlikely to be. Two high-risk HPV genotypes that are associated with the Asian region (HPV-52 and HPV-58) were found in Western Australian women suggesting a possible epidemiological link between women in these countries. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778980     DOI: 10.1002/jmv.20330

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

1.  Distribution of Human Papillomavirus Genotypes in Liquid-based Samples; Abundance of HPV-53 in Tehran, Iran.

Authors:  Mohammad Pouryasin; Heidar Sharafi; Azam-Sadat Mousavi; Shakiba Khodadad; Mahtab Marjani; Fereshteh Jamshidi; Ali Pouryasin
Journal:  Iran J Public Health       Date:  2014-08       Impact factor: 1.429

2.  Human papillomavirus, high-grade intraepithelial neoplasia and killer immunoglogulin-like receptors: a Western Australian cohort study.

Authors:  Brian Brestovac; Michelle E Wong; Raymond Tjendera; Paul J Costantino; Cyril Mamotte; Campbell S Witt
Journal:  Infect Agent Cancer       Date:  2013-09-06       Impact factor: 2.965

3.  Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.

Authors:  Leonardo M Simonella; Hazel Lewis; Megan Smith; Harold Neal; Collette Bromhead; Karen Canfell
Journal:  BMC Infect Dis       Date:  2013-03-03       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.